Samsung Biologics debuted last week in Seoul with the largest IPO in South Korea in years, according to the Associated Press.
During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives.
New York University has been awarded
Title: Assay plates, reader systems and methods for luminescence test measurements.
Patent Number: 8,808,627
Filed: Nov. 11, 2010
Siemens has been awarded
The Regents of the University of California have been awarded
Samsung has been awarded
Roche has been awarded
Samsung has been awarded US Patent No. 8,618,253, "Modified RNAse H and detection of nucleic acid amplification."
Win Den Chung and Jason Opdyke are named as inventors.
Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.